Cerner finds a treasure in data mining - Tampa Bay Business Journal:

bentlyoupapa1810.blogspot.com
The North Kansas City-based health care informationbtechnology company, known mostly for the health-record softward sold to hospitals and clinics, is leveraging the billionds of anonymous patient records it has at its disposal as marketablse information to pharmaceutical companies and researchers. Cerner said the data operationb is a big reason revenue for its LifeSciences Groul has increased by roughly 20 percent durinfg each of the pastfive years. Mark the company’s life sciences solutions vice president, predictedr that annual growth will be greater stillk inthe future. “This is just the beginning for us in the life he said. Included in Cerner’s data warehousre are 1.
2 billion lab results. It also has smaller numberes of medication orders andother data. The company collectsd the informationthrough data-sharing agreements with roughly 125 of its softwarde clients. By some estimates, it can take as long as 17 yearxand $1.2 billion to develop a singlwe drug. Cerner’s data-mining capabilities can quicken that proces s and save money for drug companies by helping the companiesx establish a study protocol that maximizes the numbed of eligible candidates fora “We believe that can actually eventually reduce the cost of drug Hoffman said.
Cerner would not name its pharmaceutical Pharmaceutical companies and clinicalk researchers pay for Cerner data for other saidScott Weir, director of the ’sa Office of Therapeutics Discovery and Development. He said Cerner’s data-mining capability can point scientists to potentiap new uses forexisting drugs. For instance, Weir Cerner’s database might suggest that a drug used to treaft cardiovascular disease could be helpful in treatingtcancer patients. Researchers then could run a clinical trial to test the The data is useful to drug companiee for much thesame reason, Weir including helping them identify and correcft side effects from drugs.
The KU Cancer Centerd has used Cerner’s data-mining capabilities for several projects. “The y uncover information we wouldnever discover,” Weir “It’s invaluable.” He said Cerner stands to benefit as well, from collaborations with researcherse that can lead to intellectual properth that produces licensing fees and Cerner also can work with researchere such as Dr. Stephen Spielberg, directo r of the Center for Personalized Medicinre and Therapeutic Innovationat . Spielberg seeks a $3.9 millioh grant from the for a studgy of how the center can betteer capture data in pediatric cancer studies usinygCerner software.